Abstract: In one aspect, a system 10 for analysing a body 14 using a device 12 is disclosed. In one arrangement and embodiment, the device 12 comprises: a controller 18; storage 20 storing electronic program instructions for controlling the controller 18; and an input means. In one form, the controller is operable, under control of the electronic program instructions, to: receive input via that input means, the input comprising at least one representation of the body 14; process the input to conduct an analysis of the body 14 and generate an output on the basis of the analysis, the processing comprising using a database 40; and communicate the output via a display 22. In an embodiment, the output comprises an estimation of an individuals three-dimensional (3D) body shape and associated body measurements, composition and health and wellness risks from a representation comprising human imagery.

Abstract: A superconducting magnet device including a plurality of superconducting magnet coils; a structural element mechanically and thermally linked to respective magnet coils to retain them in respective relative positions; and a cooling station thermally connected to a cryogenic refrigerator and to the structural element. A thermally conductive path, which passes through the structural element, is established between the cryogenic refrigerator and the superconducting magnet coils through the structural element.

Abstract: An assembly having a cylindrical structure supported by a support structure having at least one support element, the support structure being cradle shaped, such that vertical and horizontal loads are taken largely as shear forces by respective interface surfaces which are substantially parallel to the direction of the respective load, and vertical loads are taken in a direction substantially tangential to the cylindrical surface of the cylindrical structure.

Abstract: In one aspect, a system 10 for analysing a body 14 using a device 12 is disclosed. In one arrangement and embodiment, the device 12 comprises: a controller 18; storage 20 storing electronic program instructions for controlling the controller 18; and an input means. In one form, the controller is operable, under control of the electronic program instructions, to: receive input via that input means, the input comprising at least one representation of the body 14; process the input to conduct an analysis of the body 14 and generate an output on the basis of the analysis, the processing comprising using a database 40; and communicate the output via a display 22. In an embodiment, the output comprises an estimation of an individuals three-dimensional (3D) body shape and associated body measurements, composition and health and wellness risks from a representation comprising human imagery.

Abstract: The invention provides novel solid pharmaceutical dosage forms for oral administration, after being constituted in water. The solid dosage forms comprise a therapeutically effective amount of valganciclovir hydrochloride and a non-hygroscopic organic acid present in an amount sufficient to stabilize the valganciclovir hydrochloride in a predetermined amount of water. The present invention also provides novel liquid pharmaceutical dosage forms for oral administration after constituting the solid pharmaceutical dosage form with water. A non-hygroscopic bulking agent may optionally be included in the above dosage form. These novel pharmaceutical dosage forms are useful in the treatment or control of viruses such as herpes simplex virus and cytomegalovirus. The present invention also provides a method for treating these diseases employing the solid and liquid pharmaceutical dosage forms and a method for preparing these pharmaceutical dosage forms.

Abstract: An assembly having a cylindrical structure supported by a support structure having at least one support element, the support structure being cradle shaped, such that vertical and horizontal loads are taken largely as shear forces by respective interface surfaces which are substantially parallel to the direction of the respective load, and vertical loads are taken in a direction substantially tangential to the cylindrical surface of the cylindrical structure.

Abstract: A superconducting magnet device including a plurality of superconducting magnet coils; a structural element mechanically and thermally linked to respective magnet coils to retain them in respective relative positions; and a cooling station thermally connected to a cryogenic refrigerator and to the structural element. A thermally conductive path, which passes through the structural element, is established between the cryogenic refrigerator and the superconducting magnet coils through the structural element.

Abstract: For shimming a background magnetic field of a magnetic resonance imaging apparatus having an outer vacuum chamber (OVC) bore tube, a shimming arrangement has rails on the OVC bore tube and shim trays are mounted between respective rails.

Abstract: The invention provides novel solid pharmaceutical dosage forms for oral administration, after being constituted in water. The solid dosage forms comprise a therapeutically effective amount of valganciclovir hydrochloride and a non-hygroscopic organic acid present in an amount sufficient to stabilize the valganciclovir hydrochloride in a predetermined amount of water. The present invention also provides novel liquid pharmaceutical dosage forms for oral administration after constituting the solid pharmaceutical dosage form with water. A non-hygroscopic bulking agent may optionally be included in the above dosage form. These novel pharmaceutical dosage forms are useful in the treatment or control of viruses such as herpes simplex virus and cytomegalovirus. The present invention also provides a method for treating these diseases employing the solid and liquid pharmaceutical dosage forms and a method for preparing these pharmaceutical dosage forms.

Abstract: A monitoring system for monitoring an offshore construction is presented. The offshore construction to be monitored comprises mutually mechanically coupled marine assets. The monitoring system comprises a data storage unit, an intrusion detection service, an input device, and an update service. The data storage unit stores data specifying a spatial range of at least one warning zone pertaining to the offshore construction. The intrusion detection service is provided to detecting an intrusion of the spatial range and for issuing an alert message upon such detection. The input device receives position information for one or more of the marine assets. The update service updates the spatial range of the at least one warning zone based on the received position information. Additionally a monitoring method and a computer program product are provided.

Abstract: The present invention provides novel solid pharmaceutical dosage forms for oral administration, after being constituted in water. The solid dosage forms comprise a therapeutically effective amount of valganciclovir hydrochloride and a non-hygroscopic organic acid present in an amount sufficient to stabilize the valganciclovir hydrochloride in a predetermined amount of water. The present invention also provides novel liquid pharmaceutical dosage forms for oral administration after constituting the solid pharmaceutical dosage form with water. A non-hygroscopic bulking agent may optionally be included in the above dosage form. These novel pharmaceutical dosage forms are useful in the treatment or control of viruses such as herpes simplex virus and cytomegalovirus. The present invention also provides a method for treating these diseases employing the solid and liquid pharmaceutical dosage forms and a method for preparing these pharmaceutical dosage forms.

Abstract: An arrangement for shimming a background magnetic field of a magnetic resonance imaging apparatus having an outer vacuum chamber (OVC) bore tube (1). Rails (8, 9) are provided on the OVC bore tube and shim trays (4) are mounted between respective rails.

Abstract: The present invention provides novel solid pharmaceutical dosage forms for oral administration, after being constituted in water. The solid dosage forms comprise a therapeutically effective amount of valganciclovir hydrochloride and a non-hygroscopic organic acid present in an amount sufficient to stabilize the valganciclovir hydrochloride in a predetermined amount of water. The present invention also provides novel liquid pharmaceutical dosage forms for oral administration after constituting the solid pharmaceutical dosage form with water. A non-hygroscopic bulking agent may optionally be included in the above dosage form. These novel pharmaceutical dosage forms are useful in the treatment or control of viruses such as herpes simplex virus and cytomegalovirus. The present invention also provides a method for treating these diseases employing the solid and liquid pharmaceutical dosage forms and a method for preparing these pharmaceutical dosage forms.

Abstract: A monitoring system for monitoring an offshore construction is presented. The offshore construction to be monitored comprises mutually mechanically coupled marine assets. The monitoring system comprises a data storage unit, an intrusion detection service, an input device, and an update service. The data storage unit stores data specifying a spatial range of at least one warning zone pertaining to the offshore construction. The intrusion detection service is provided to detecting an intrusion of the spatial range and for issuing an alert message upon such detection. The input device receives position information for one or more of the marine assets. The update service updates the spatial range of the at least one warning zone based on the received position information. Additionally a monitoring method and a computer program product are provided.

Abstract: An arrangement for supporting a cylindrical superconducting coil structure has recesses in an axial end-surface of the coil structure, and support brackets that individually horizontally protrude into the recesses, such that a vertical loading on the support brackets bears the weight of the coil structure. Opposite ends of the support brackets engage a support member, which supports the support brackets engaged therein, thereby also bearing the weight of the coil structure.

Abstract: The present invention provides novel solid pharmaceutical dosage forms for oral administration, after being constituted in water. The solid dosage forms comprise a therapeutically effective amount of valganciclovir hydrochloride and a non-hygroscopic organic acid present in an amount sufficient to stabilize the valganciclovir hydrochloride in a predetermined amount of water. The present invention also provides novel liquid pharmaceutical dosage forms for oral administration after constituting the solid pharmaceutical dosage form with water. A non-hygroscopic bulking agent may optionally be included in the above dosage form. These novel pharmaceutical dosage forms are useful in the treatment or control of viruses such as herpes simplex virus and cytomegalovirus. The present invention also provides a method for treating these diseases employing the solid and liquid pharmaceutical dosage forms and a method for preparing these pharmaceutical dosage forms.

Abstract: Methods of reducing power consumption in a USB power-delivery source device. In one such method, one or more source capabilities messages are sent by the USB power-delivery source device. If, after sending a source capabilities message, a response to said source capabilities message is not received within a predetermined time period, the device sends another source capabilities message. If, after sending a predetermined number of source capabilities messages, no response is received, the device waits an extended period of time before sending another source capabilities message. Receiving functionality of the USB power-delivery source device is turned off during some or all of said extended period of time.

Abstract: An arrangement for supporting a cylindrical superconducting coil structure has recesses in an axial end-surface of the coil structure and support brackets protruding into the recesses, such that a vertical loading on the support brackets bears the weight of the coil structure.

Abstract: The present invention provides novel solid pharmaceutical dosage forms for oral administration comprising a bisphosphonate, or a pharmaceutically acceptable salt thereof, which bisphosphonate is present in an amount not therapeutically effective when the bisphosphonate is orally administered alone, and a modified amino acid carrier, or a pharmaceutically acceptable salt thereof, which modified amino acid carrier is present in an amount effective to facilitate absorption of the bisphosphonate in the gastrointestinal tract such that the bisphosphonate is therapeutically effective. The ratio of bisphosphonate to modified amino acid carrier is from about 1:30 to about 1:1, respectively. These novel solid pharmaceutical dosage forms are useful in the treatment or control of bone diseases and particular disorders in calcium metabolism, including, for example, osteoporosis, hypercalcaemia of cancer, and the treatment of metastatic bone pain.

Abstract: An activation device for a patient alarm system. The activation device comprises a resiliently deformable bladder defining an internal volume and a pressure switch in fluid communication with the internal volume and connected to an alarm system. Squeezing the resiliently deformable bladder operates the pressure switch, which activates the alarm system.